Cargando…

Immunological effects of convalescent plasma therapy for coronavirus: a scoping review

BACKGROUND: Preliminary studies revealed the safety and effectiveness of convalescent plasma (CP) therapy for patients with coronavirus. In this study, we aimed to evaluate and summarize the available evidence on CP therapy, identify the research gap regarding the immunological response to CP therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esmaeili, Behnaz, Esmaeili, Shahnaz, Pourpak, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708512/ https://www.ncbi.nlm.nih.gov/pubmed/34952570 http://dx.doi.org/10.1186/s12879-021-06981-0

Ejemplares similares

Human Neutrophil Antigen Genotype and Allele Frequencies in Iranian Blood Donors
por: Esmaeili, Behnaz, et al.
Publicado: (2022)

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients
por: Shu, Zhanjun, et al.
Publicado: (2021)

The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Shi, Ming, et al.
Publicado: (2021)

COVID-19 convalescent plasma composition and immunological effects in severe patients
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2021)

Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease
por: Das, Sudipta Sekhar, et al.
Publicado: (2020)

Empowering Health Care Providers and Self-management Education in Diabetes? A Scoping Review
por: Aalaa, Maryam, et al.
Publicado: (2021)

Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review
por: Grisolia, Gianpaolo, et al.
Publicado: (2020)

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
por: Piyush, Ravikant, et al.
Publicado: (2020)

Iran diabetes research study; knowledge discovery in diagnosis: a scoping review
por: Fana, Saeed Ebrahimi, et al.
Publicado: (2021)

Olfactory and Gustatory Dysfunction in 2019 Novel Coronavirus: An Updated Systematic Review and Meta-analysis
por: Esmaeili, Marzieh, et al.
Publicado: (2021)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

Evidence Gap and Knowledge Map of Physical Activity Research in Diabetes in Iran: A Scoping Review
por: Sanjari, Mahnaz, et al.
Publicado: (2021)

Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
por: Augustin, Max, et al.
Publicado: (2023)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19
por: Raychaudhuri, Deblina, et al.
Publicado: (2022)

Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
por: Im, Jae Hyoung, et al.
Publicado: (2020)

Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19)
por: Alghamdi, Ahmed N., et al.
Publicado: (2020)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
por: Hassan, Mozan Osman, et al.
Publicado: (2020)

Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
por: Raturi, Manish, et al.
Publicado: (2021)

Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019
por: Hartog, Nicholas, et al.
Publicado: (2021)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
por: Ouyang, Jing, et al.
Publicado: (2020)

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy and immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates
por: Verma, Henu Kumar, et al.
Publicado: (2020)

The true historical origin of convalescent plasma therapy
por: Marson, Piero, et al.
Publicado: (2020)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
por: Iranijam, Effat, et al.
Publicado: (2022)

Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
por: Rahardjo, Theresia Monica, et al.
Publicado: (2021)

Effect of time and titer in convalescent plasma therapy for COVID-19
por: de Candia, Paola, et al.
Publicado: (2021)

Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020)

Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report
por: Omrani, Ali S., et al.
Publicado: (2020)

Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
por: Li, Pei Ye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4k0q3kiath1mi7t0b32u62obbu